Gregory Kricorian

7PUBLICATIONS
28CO-AUTHORS
Epidemiological methodsMolecular targetsMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 26, 2026
Prevalence of Atopic Dermatitis in the United States, 2019-2023: National, State, and County-Level Estimates from Administrative Claims Data.

|Feb 27, 2025
ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis.

Emma Guttman-Yassky, Eric Simpson, Robert Bissonnette

|Jan 18, 2024
OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target.

Michael Croft, Ehsanollah Esfandiari, Camilla Chong

|Apr 15, 2023
Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid Arthritis.

Jeffrey R Curtis, Paul Emery, Greg Kricorian

|Nov 18, 2020
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission.

Jeffrey R Curtis, Paul Emery, Elaine Karis

|Sep 03, 2020
Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data.

Dimitrios A Pappas, Heather J Litman, Tamara Lesperance

Pageof 2

Frequent Collaborators

3 joint publications

Emma Guttman-Yassky

3 joint publications

Kenji Kabashima

2 joint publications

Andreas Wollenberg

2 joint publications

Elaine Karis